Celularity (CELUW) Assets Average (2019 - 2025)
Celularity (CELUW) reported Assets Average of $110.8 million for Q4 2025, down 15.28% year-over-year from $130.8 million in Q4 2024, and down 5.52% quarter-over-quarter from $117.3 million in Q3 2025.
Celularity (CELUW) Assets Average (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Assets Average data on file, last reported at $110.8 million in Q4 2025.
- Assets Average for Q4 2025 came in at $110.8 million, down 15.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $110.8 million (down 15.28% YoY), and the FY2025 annual result was $120.0 million, down 13.22% from the prior year.
- Assets Average declined to $110.8 million in Q4 2025 per CELUW's latest filing, from $117.3 million in the prior quarter.
- Over five years, Assets Average peaked at $433.2 million in Q3 2022 and troughed at $110.8 million in Q4 2025.
- A 5-year average of $253.4 million and a median of $206.0 million in 2021 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2023: Assets Average soared 105.44% in 2022, then sank 64.08% in 2023.
- A 5-year view of Assets Average shows it stood at $431.2 million in 2021, then dropped by 2.81% to $419.1 million in 2022, then slumped by 64.08% to $150.5 million in 2023, then slipped by 13.14% to $130.8 million in 2024, then fell by 15.28% to $110.8 million in 2025.
- Business Quant data shows CELUW's Assets Average at $110.8 million in Q4 2025, $117.3 million in Q3 2025, and $124.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 110.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 110.78 Mn |
| Sep 30, 2025 | 117.26 Mn |
| Jun 30, 2025 | 124.58 Mn |
| Mar 31, 2025 | 130.78 Mn |
| Dec 31, 2024 | 130.76 Mn |
| Sep 30, 2024 | 132.17 Mn |
| Jun 30, 2024 | 139.66 Mn |
| Mar 31, 2024 | 143.85 Mn |
| Dec 31, 2023 | 150.54 Mn |
| Sep 30, 2023 | 201.81 Mn |
| Jun 30, 2023 | 304.42 Mn |
| Mar 31, 2023 | 381.74 Mn |
| Dec 31, 2022 | 419.09 Mn |
| Sep 30, 2022 | 433.23 Mn |
| Jun 30, 2022 | 431.77 Mn |
| Mar 31, 2022 | 424.17 Mn |
| Dec 31, 2021 | 431.21 Mn |
| Sep 30, 2021 | 288.35 Mn |
| Jun 30, 2021 | 210.17 Mn |
| Mar 31, 2021 | 361.47 Mn |